Search results
People also ask
Who is Dr Steven Kao?
Is Dr. Kao a good doctor?
Who is Dr. Eric Kao?
Who is Dr Mark Kao?
Who is Dr Shawn Kao?
Who is Dr John Kao?
A/Prof Steven Kao is a medical oncologist at the Chris O’Brien Lifehouse. Steven has a wide clinical, translational and psycho-social research interest in thoracic cancers including malignant mesothelioma and asbestos-related lung cancers.
- May Whitaker
May Whitaker Head of Physics and Engineering, Deputy...
- Why Chris O'Brien Lifehouse
Patients treated at comprehensive cancer centres live...
- Appointments & Referrals
Speak to an expert, call askChrisOBrienLifehouse on (02)...
- Careers
Though it is an incredibly rewarding profession, we know...
- Contact Us
Breast Screen (02) 9515 0047: Breast Oncology Department...
- Our Services
Pathology Collection Centre. Monday 7:30am – 5:00pm. Tuesday...
- May Whitaker
Associate Professor Steven Kao is a Medical Oncology Senior Staff Specialist at the Chris O’Brien Lifehouse and a Honorary Visiting Medical Officer at Royal Prince Alfred Hospital in Sydney, Australia. He is also the clinical research lead at the Asbestos and Dust Diseases Research Institute.
I did a PhD on mesothelioma, and now, I work to enhance patient outcomes through clinical research, trials, and face-to-face treatment. At the Chris O’Brien Lifehouse, I oversee the thoracic...
- 457
- Chris O'brien Lifehouse
- 476
Dr Steven Kao is a staff specialist in medical oncology at Chris O’Brien Lifehouse (COBL) and also has a position as a research fellow at the Asbestos Diseases Research Institute (ADRI). As a medical oncologist in his practice, he specialises in the management of thoracic cancer patients.
Steven KAO | Cited by 1,006 | of The University of Sydney, Sydney | Read 20 publications | Contact Steven KAO
Dr Steven Kao is a Medical Oncologist at Chris O’Brien Lifehouse. He completed his PhD at the Asbestos Diseases Research Institute and focused his research on predictive and prognostic factors in malignant mesothelioma.
Dec 2, 2019 · Medical oncologist Dr Steven Kao was one of the four panel members, and spoke on the leaps and bounds made in treatment options in the last ten years. “We’ve discovered the importance of targets in lung cancer because we’ve now got drugs to control the cancers.